focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,783.50
Bid: 1,780.00
Ask: 1,780.50
Change: -29.00 (-1.60%)
Spread: 0.50 (0.028%)
Open: 1,792.50
High: 1,802.00
Low: 1,775.50
Prev. Close: 1,812.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET CLOSE: Strong US data, Wall Street earnings lift stocks

Thu, 15th Apr 2021 16:56

(Alliance News) - Stock prices in London ended higher on Thursday, with miners helping to lift the FTSE 100 and GlaxoSmithKline posting hefty share price gains, though Deliveroo failed to inspire with its maiden trading update as a listed company.

Across the Atlantic, focus was on strong US retail sales numbers and falling jobless claims figures, while the Wall Street corporate earnings calendar continued with updates from Citigroup, Bank of America and PepsiCo.

The FTSE 100 index rose 43.92 points, or 0.6%, to close at 6,983.50. The mid-cap FTSE 250 ended the session 116.59 points, or 0.5%, higher at 22,472.04.

The mid-cap index hit another record closing high, while the blue-chip counterpart edges closer to 7,000 points, levels last seen in February 2020.

The AIM All-Share index closed up 4.22 points, 0.3%, at 1,248.13 on Thursday.

The Cboe UK 100 index ended up 0.7% at 695.73. The Cboe 250 closed up 0.6% at 20,096.78. The Cboe Small Companies closed up 1.0% at 14,567.33.

"European stocks are charging higher after the US earning season kicked off on the right foot. US banks are often considered a proxy for the broader economy. As a result, their earnings are strong drivers of sentiment," OANDA analyst Sophie Griffiths noted.

On Wall Street, the Dow Jones Industrial Average was up 0.8% shortly before the market close in London. The S&P 500 rose 0.9% and the Nasdaq Composite jumped 1.0%.

Bank of America said it expects an accelerated recovery going forward as its income increased in the first quarter of 2021. In addition, the North Carolina, US-based bank said it will repurchase up to USD25 billion of stock over time.

Revenue in the three months to the end of March slipped to USD8.07 billion from USD9.13 billion the year before, but pretax income rose to USD871 million versus USD582 million the year prior.

BofA lowered its provision for credit losses by a massive USD6.6 billion to a benefit of USD1.9 billion.

Citigroup reported growth in earnings in the first quarter - thanks to credit releases - and has set out to restructure its underperforming Global Consumer Banking unit by "doubling down" on its wealth business.

In the three months to March 31, the New York-headquartered universal bank saw net income more than triple to USD7.94 billion from USD2.54 billion.

In New York, BofA shares were down 4.2%, while Citi lost 1.5%.

"The upbeat numbers served to reinforce expectations of a strong US economic recovery. If the world's largest economy is performing well, this is good news for the global economy and risk sentiment," Griffiths added.

Adding to the positive sentiment, US retail sales growth surged in March as government stimulus payments made their way to households. On a monthly basis, US retail sales jumped 9.8% in March, rebounding from a 2.7% fall in February. The figure was well above the market estimate, cited by FXStreet, of 5.9%.

Elsewhere, the Department of Labor said in the week ending April 10, the advance figure for seasonally adjusted initial claims was 576,000, down sharply from 769,000 claims the week before. The latest reading was well below market expectations of 700,000.

In Frankfurt, the DAX 30 ended 0.3% higher, while the CAC 40 rose 0.4%.

The EU said Wednesday that it is expecting 50 million Pfizer coronavirus vaccine doses earlier than expected, as the US said it would continue a pause in vaccinations using the Johnson & Johnson shot for at least another week so regulators can assess possible blood clot links.

The EU's vaccination campaign has picked up speed recently after a difficult beginning.

In London, GlaxoSmithKline ended as one of the best blue-chip performers, up 5.0%.

Activist investor Elliot Management has taken a multi-billion-pound stake in pharmaceutical giant, the Financial Times reported on Thursday.

The FT said Elliot's stake was confirmed by people with knowledge of the investment and is a "significant" position, according to one of them. The newspaper reported that Elliot's investment comes as GSK shareholders have become disillusioned with the leadership of Chief Executive Emma Walmsley.

Miners also rose. Antofagasta added 3.4%, BHP climbed 1.5% and Rio Tinto rose 2.3%.

Metal prices were on the up as the dollar's strength waned and amid expectations of strong economic growth in China.

Gross domestic product data from China is reported overnight on Friday.

Gold was trading at USD1,766.35 an ounce at the London equity market close Thursday, up from USD1,736.27 on Wednesday.

The pound was quoted at USD1.3788 at the London equities close on Thursday, down slightly from USD1.3793 on Wednesday. The euro was priced at USD1.1965, down from USD1.1975. Against the Japanese yen, the dollar was quoted at JPY108.71, down from JPY108.96.

Back in London, Unilever rose 1.1% and in Zurich, Nestle also climbed 0.5%. The duo ended higher after Pepsi reported a sharp rise in income in the first quarter and guided for further growth in the second quarter on vaccination efforts expected to boost the food and beverages industry, especially when people start to travel again.

Pepsi was up 0.5% in New York.

In the three months to March 31, the food, snack, and beverage giant recorded net income of USD1.72 billion, up 27% from USD1.35 billion the year before.

Deliveroo shares fell 3.2% and now sit about a third lower than the IPO price of 390 pence.

Deliveroo maintained its full-year guidance after a sharp acceleration in orders in the first quarter, though cautiously eyed a relaxation of lockdown rules ahead.

In its maiden trading update as a London-listed company, Deliveroo said it made "significant progress" in the first quarter ended March 31, with total orders more than doubling to 71 million from 33 million.

IG Markets analyst Chris Beauchamp commented: "Those hoping for a rebound in Deliveroo shares after the Q1 update this morning have been disappointed afresh, with the shares taking another turn lower despite the anticipated bounce in order volumes.

"Crucially, fears about a changing environment thanks to the end of lockdown restrictions appear to be justified, with the firm leaving guidance unchanged and noting that the end of 'special circumstances' would make it hard to issue accurate forecasts for the coming few months."

Brent oil was trading at USD66.58 a barrel late Thursday, up from USD66.32 late Wednesday.

Friday's economic calendar has a spate of data from China overnight, including the GDP reading, retail sales and industrial output.

Friday's local corporate calendar has a trading statement from emerging markets-focused asset manager Ashmore Group and private hospital operator Mediclinic International. In the US, Morgan Stanley reports first-quarter results.

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more
30 Apr 2024 12:22

Sensodyne-maker Haleon to shut UK plant, 435 jobs to go

April 30 (Reuters) - Haleon, the world's largest standalone consumer healthcare firm, will shut its UK production site which makes Sensodyne toothpastes by 2026, leading to 435 job losses, a spokesperson said on Tuesday.

Read more
25 Apr 2024 15:53

GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology

April 25 (Reuters) - GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing them of infringing GSK patents related to messenger RNA (mRNA) technology in the companies' blockbuster COVID-19 vaccines.

Read more
24 Apr 2024 14:19

UK earnings, trading statements calendar - next 7 days

Thursday 25 April 
Aquila European Renewables PLCFull Year Results
Argo Blockchain PLCFull Year Results
AstraZeneca PLCQ1 Results
Barclays PLCQ1 Results
Checkit PLCFull Year Results
Coca-Cola Europacific Partners PLCTrading Statement
Destiny Pharma PLCFull Year Results
Dillistone Group PLCFull Year Results
Focusrite PLCHalf Year Results
Gem Diamonds LtdTrading Statement
Hikma Pharmaceuticals PLCTrading Statement
Hummingbird Resources PLCTrading Statement
Ibstock PLCTrading Statement
Inchcape PLCTrading Statement
J Sainsbury PLCFull Year Results
London Stock Exchange Group PLCQ1 Results
Persimmon PLCTrading Statement
Pinewood Technologies Group PLCFull Year Results
PPHE Hotel Group LtdTrading Statement
PureTech Health PLCFull Year Results
Relx PLCTrading Statement
Renewi PLCTrading Statement
Schroders PLCQ1 Results
Skillcast Group PLCFull Year Results
Travis Perkins PLCTrading Statement
Trifast PLCTrading Statement
Unilever PLCQ1 Results
WAG Payment Solutions PLCTrading Statement
Weir Group PLCTrading Statement
WH Smith PLCHalf Year Results
WPP PLCTrading Statement
Zinc Media Group PLCFull Year Results
Friday 26 April 
Facilities by ADF PLCFull Year Results
Kingspan Group PLCTrading Statement
Loungers PLCTrading Statement
NatWest Group PLC Q1 Results
Pearson PLCTrading Statement
Record PLCTrading Statement
Smurfit Kappa Group PLCTrading Statement
Taylor Maritime Investments LtdTrading Statement
Monday 29 April 
Beazley PLCTrading Statement
Biome Technologies PLCFull Year Results
Christie Group PLCFull Year Results
Gresham House Energy Storage Fund PLCFull Year Results
Gresham Technologies PLCFull Year Results
Jadestone Energy PLCFull Year Results
Oxford BioMedica PLCFull Year Results
SpaceandPeople PLCFull Year Results
Tuesday 30 April 
Avacta Group PLCFull Year Results
Card Factory PLCFull Year Results
Capital & Regional PLCFull Year Results
Close Brothers Group PLCTrading Statement
Coca-Cola HBC AGTrading Statement
Elementis PLCTrading Statement
essensys PLCHalf Year Results
Fadel Partners IncFull Year Results
Glencore PLCTrading Statement
Hargreaves Lansdown PLC Trading Statement
Howden Joinery PLCTrading Statement
HSBC Holdings PLCQ1 Results
Kelso Group PLCFull Year Results
Northcoders Group PLCFull Year Results
Phoenix Spree Deutschland LtdFull Year Results
RBG Holdings PLCFull Year Results
Rotork PLCTrading Statement
Safestore Holdings PLCHalf Year Results
Shield Therapeutics PLCFull Year Results
St James's Place PLCTrading Statement
Strip Tinning Holdings PLCFull Year Results
Whitbread PLCFull Year Results
Wednesday 1 May 
Computacenter PLCTrading Statement
GSK PLCQ1 Results
Haleon PLCTrading Statement
HSS Hire Group PLCFull Year Results
Intelligent Ultrasound Group PLCFull Year Results
Maintel Holdings PLCFull Year Results
Next PLCTrading Statement
Smith & Nephew PLCTrading Statement
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
24 Apr 2024 09:21

GSK's endometrial cancer drug receives FDA approval

(Sharecast News) - Drugmaker GSK said on Wednesday that the US Food and Drug Administration has accepted a supplemental Biologics License Application for Jemperli, its drug aimed at treating endometrial cancer.

Read more
24 Apr 2024 09:14

GSK's Jemperli with chemotherapy accepted for priority review by FDA

(Alliance News) - GSK PLC on Wednesday said that the US Food & Drug Administration has accepted a supplemental biologics licence application for Jemperli, when used in combination with chemotherapy.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.